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ABSTRACT
Introduction: It is hypothesized that a good 
partnership between asthma patients and their 
physicians has a direct and positive influence 
on the patients’ clinical and patient-reported 
outcomes. Conversely, poor partnership has 
a detrimental effect on clinical and patient-
reported outcomes. This paper uses data from 
a real-world observational study to define 
partnership through matched physician 
and patient data and correlate the quality of 
partnership with observed clinical and patient-
reported outcomes. Methods: Data were drawn 
from Adelphi’s Respiratory Disease Specific 
Programme, a cross-sectional study of consulting 
patients in five European countries undertaken 
between June and September 2009. A range of 
clinical and patient-reported outcomes were 
observed allowing analysis of the partnership 
between 2251 asthma patients and their 




the better the partnership between patient and 
physician, the more likely the patient is to have 
their asthma condition controlled (P<0.001), 
to experience fewer exacerbations (P<0.001), 
to have better quality of life (P<0.001), to have 
fewer sleep disturbances (P<0.001), and to have 
fewer patient-reported symptoms (P<0.001). 
Partnership is also associated with lower 
impact on lifestyle (P<0.01) and reduced days 
lost at work/school (P<0.05), and with patient 
satisfaction with their inhaler device (P<0.05). 
Conclusion: The patient-physician partnership 
is a contributory factor in the improvement of 
asthma treatment, and patient education may 
lead to improvement in a patient’s ability to 
contribute to this. Device satisfaction is one of 
the markers of good partnership.
Keywords: asthma; device; partnership; patient; 
physician; real world
INTRODUCTION
Asthma is a common inflammatory condition 
of the upper respiratory tract estimated to affect 
approximately 300 million people worldwide1 
and with prevalence increasing globally by 50% 
every decade.2
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Recent studies in Europe,3 the US,4 Japan,5 and 
the Asia-Pacific region6 indicate that asthma is 
underdiagnosed and undertreated and that there 
is considerable room for improvement in control 
of the condition. It has been demonstrated that 
optimal communication between the physician 
and patient is required for outcomes to be 
improved.7 These needs have given rise to the 
concept of a “patient-physician” partnership, 
the importance of which has been recognized 
across most medical communities.8,9
This paper focuses on the behavioral and 
attitudinal evidence collected by one research-
based organization (Adelphi, Macclesfield, UK) 
under the label of Disease Specific Programmes 
(DSPs®). The DSPs are large, multinational, 
observational studies of clinical practice, 
designed to capture a cross-section of real-
world data. These are an established method 
for investigating current treatment practices 
across a wide range of disease areas.10 The 
Respiratory DSP accurately reflects the current 
symptom prevalence and severity and associated 
treatment practices of respiratory conditions 
including asthma.11
This paper investigates the relationship 
between the patient and physician partnership 
and real-world clinical outcomes. It seeks 
to establish an objective assessment of the 
degree of partnership and compare the degree 




The Respiratory DSP was conducted between 
June and September 2009, recruiting specialists 
and primary-care physicians and their patients 
in France, Germany, Italy, Spain, and the UK. 
The full methodology for this survey, including 
limitations of the DSP approach, has been 
outlined previously.10,11 Physicians completed 
a patient record form (PRF) for six consecutive 
consulting adult asthma patients, and the same 
patients were invited to fill out a patient self-
completion form (PSC).
Physicians were identified by the local 
DSP fieldwork teams from public lists of 
healthcare professionals according to predefined 
selection criteria to ensure that the sample was 
representative of asthma management in each 
participating country. Physicians were checked 
for their eligibility to participate in the DSP in 
terms of specialty, location (hospital or office), 
whether they were personally responsible for 
treatment decisions, and how many patients 
they saw in a typical week (in total and with 
asthma in order to avoid physicians with an 
abnormal workload). Candidate respondents 
who met the predefined eligibility criteria were 
subsequently invited to participate in the study. 
To avoid potential selection bias due to variable 
population densities in different geographical 
regions in a given country, an appropriately 
larger sample of physicians was identified in 
densely populated areas than in more sparsely 
populated areas. As the methodology requires 
the next six presenting asthma patients for each 
physician, the DSP sample is representative of 
the consulting population.
All responses were anonymous to preserve 
patient confidentiality and to avoid bias at the 
data collection and analysis phases. The study 
protocol followed ethical procedures including 
informed consent of all patients for anonymous 
and aggregated reporting of research findings 
based on the questionnaires employed. Patients 
were instructed by the physician to complete 
the PSC independently and return it in a 
sealed envelope. Matching the physician and 
patient responses via patient/physician study 
numbers allowed the PSC data to be linked with 
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comparable data recorded on the physician-
completed PRF to highlight any areas of disparity 
and/or agreement. The analyses conducted for 
the purposes of this paper investigate data from 
the matched PRF and PSC records.
A number of limitations of the DSP 
methodology should be noted. Although 
respondent physicians are requested to collect 
data on a series of consecutive patients to avoid 
selection bias, in the absence of randomization, 
this is contingent upon the integrity of the 
participating respondent rather than formalized 
source verification procedures. Moreover, 
diagnosis in the target patient group is based 
primarily on the judgment and diagnostic 
skills of the respondent physician rather than 
on a formalized diagnostic checklist. Although 
the DSP can be used to identify association, a 
further limitation is that being cross-sectional, 
it cannot be used to demonstrate cause 
and effect.
Defining Patient and Physician Partnership
The  inves t iga tor s  r ecognize  that 
communication is a key factor in measuring the 
degree of partnership between the patient and 
the physician. The PRF and PSC records include 
six directly comparable questions for which the 
possible responses from the patient and the 
physician are identical and which the authors 
suggest provide a measure of communication 
and therefore partnership. These are:
Perceived asthma severity•	
Impact of condition on daily living, •	
including sleep, getting up, daily activities, 
mood, relationships, leisure time, and work/
school (each assessed individually)
Presence of the following three primary •	
symptoms in the past 4 weeks: shortness 
of breath when exercising, cough, 
and wheezing
Time of day of symptoms (presence of •	
daytime and or nighttime symptoms)
Frequency of daytime symptoms in the past •	
4 weeks
Frequency of rescue inhaler usage in the •	
past 4 weeks.
An arbitrary scoring system sensitive to 
the direction of the patient and physician 
mismatch was used to measure the level of 
alignment between them. An alignment score 
was calculated for each variable and the mean 
of these scores taken to produce a standardized 
score of between –1 and 1 for each patient. A 
score of zero indicates patient and physician 
were in perfect alignment. If a physician 
overstates the impact of asthma relative to a 
particular patient then that patient receives a 
positive score with maximum of 1. If a physician 
understates the patient’s condition relative to 
the patient then that record receives a negative 
score with minimum of –1. The main strength 
of this model was that no arbitrary division of 
patients needed to be applied to the data and all 
patients could be included with an individual 
alignment score. Each variable of the alignment 
definition carried an equal weighting.
Where ordinal data were present (severity, 
impact of condition, frequency of daytime 
symptoms, and frequency of rescue inhaler 
usage), patients were assigned a higher score 
depending on the degree of mismatch. For 
example, on a 1-7 scale measuring the impact of 
asthma, every one-point difference between the 
patient and physician was given a score of 0.17 
up to a maximum of 1 where the physician and 
patient rating differed by six points.
Relationship Between Partnership and 
Clinical Outcomes
The following clinical outcomes were analyzed 
against the degree of partnership between patient 
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and physician: physician perception of highest 
achievable control, number of exacerbations in 
the past 12 months, EQ-5D utility score, frequency 
of sleep disturbances in the past 4 weeks (as 
measured by the Jenkins Sleep Scale),12 number 
of increases in symptoms not severe enough to 
visit the physician (as reported by patients). The 
following patient-reported outcomes were also 
analyzed: number of days lost (work/school), 
overall satisfaction with inhaler, and restrictions 
on lifestyle as a result of their asthma condition. 
Patients were asked to rate the restriction on their 
lifestyle on a five-point scale in six areas:
What they could do in the last 12 months •	
compared with what they used to be able 
to do
How often they participate in sporting •	
activities
How much t ime they spend in •	
sporting activities
Social life, holidays, and leisure activities•	
Activities avoided to prevent asthma •	
worsening
Outdoor activities during the winter or •	
pollen season.
This resulted in a patient score between 5 
(no restriction on lifestyle) and 30 (highest 
restriction on lifestyle).
In addition, patient age, gender, country, 
current/previous job, smoking status, and 
number of visits to any physician in the last 
12 months were analyzed to determine whether 
these have any relationship with the patient and 
physician partnership.
Statistical Methods
The relationship between alignment score 
and each clinical outcome/variable was plotted 
using generalized additive models (GAM)13 to 
produce a smooth curve for each effect. EQ-5D 
utility score and age showed departures from 
linearity. The other variables all produced 
straight-line relationships once distributions had 
been normalized. GAMs employ sophisticated 
techniques that find the best additive functional 
form of the predictors (not necessarily linear) 
that model the expectation of the response 
variable. With flexibility in choosing functional 
form there is an inherent danger of over-
fitting, a situation in which the derived model 
is inaccurate for predicting responses outside 
of the study sample due to its complexity. To 
combat this, GAMs include parameter(s) that 
penalize the complexity of the model (often 
based on the second derivative of the complex 
function—absolute values further away from 
zero incurring more penalty—further away from 
a linear function with 0 second derivative).13
Optimal values for these penalization 
factors can be estimated using cross-validation 
techniques, where part of the sample is not 
used to fit the model but is only used to assess 
its predictive accuracy (measured as the average 
across n replications where n is the sample 
size—each time dropping a separate single 
observation, estimating parameters on the 
reminder, and assessing predictive accuracy on 
this omitted observation).
For this study, the full model, including 
all the fixed effects, incorporated a random 
variable/effect for physician in order to model 
the variability between physicians irrespective 
of their patients. This type of analysis is 
referred to as a Generalized Additive Mixed 
Model (GAMM).13,14
In terms of model specifics, nonlinear 
variables were modeled using penalized thin-plate 
regression splines (see Wood13 for a more detailed 
explanation). The model was fitted using restricted 
maximum likelihood (REML). REML is often the 
preferred method over maximum likelihood 
(ML) because it is less likely to underestimate the 
variance in the model.15 This is especially true 
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when the number of fixed parameters is large.13 
All analysis was conducted in R version 2.10.0.16
RESULTS
A total of 582 physicians participated in 
the study (Table 1). Matched PRFs and PSCs 
were analyzed for a total of 2251 adult asthma 
patients (France 427; Germany 667; Italy 558; 
Spain 442; UK 157).
Figure 1 shows the outcomes and parameters 
that are significantly associated with patient-
physician partnership (in black and grey) 
and those not associated with partnership 
(in white). The former are mainly related 
to severity of the disease and experience of 
symptoms and include: physician perception 
of highest achievable control for each patient; 
physician-recorded number of exacerbations 
in the last 12 months; EQ-5D utility score; 
patient-recorded sleep disturbances in the 
past 4 weeks; and the number of symptom 
increases in the last 12 months not severe 
enough to prompt a visit to the physician 
(P<0.001 for each). Parameters that impact on 
the patient’s daily living, including restrictions 
on lifestyle (P<0.01) and number of days 
lost at work or school in the last 12 months 
(P<0.05), are also significantly associated 
with patient-physician partnership, as is the 
patient’s overall satisfaction with their inhaler 
device (P<0.05). Parameters not significantly 
associated with patient-physician partnership 
include: country, nature of employment, 
Table 1. Study physicians distribution and profiles.
France Germany Italy Spain UK Total
PCPs 50 50 50 50 52 252
Specialists 70 70 70 70 50 330
Total 120 120 120 120 102 582
PCPs=primary care physicians.
Figure 1. Parameters for which there is or is not a significant association with partnership between patient and physician.












Overall satisfaction with inhaler
No. of days lost at work/school in past 12 months due to asthma
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No. of symptom increases in past 12 months not severe enough to prompt visit to physician
Frequency of sleep disturbances in past 4 weeks
EQ-5D utility score
No. of exacerbations in past 12 months (physician recorded)
Highest achievable control (physician perception)
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patient age, patient gender, smoking status, 
and number of visits to any physician in the 
last 12 months.
These findings are further illustrated in 
Figures 2-6. In Figure 2, the GAMM analysis 
demonstrates that better partnership between 
patient and physician is associated with better 
asthma control (as perceived by the physician). 
Patients whose asthma is controlled have a 
mean alignment difference of 0.023 compared 
with 0.03 among patients whose asthma is 
not controlled.
Similarly, in Figures 3-6, better partnership 
is associated with fewer exacerbations, better 
quality of life (as measured by EQ-5D utility 
score), fewer sleep disturbances (as measured 
by Jenkins’ sleep scale), and fewer patient-
reported symptoms. In each case, as the degree 
of alignment increases, the clinical outcome is 
better. This pattern is also observed when GAMM 
analysis is applied to impact on daily living 
(Figures 7-8), where as alignment increases, 
patients are more likely to report lower restriction 
on their lifestyle and reduced days lost at 
work/school.
Finally, it was observed that patient 
satisfaction with device was significantly 
Figure 2. Better patient-physician partnership is associated 
with control of asthma (as perceived by the physician; 
P<0.001).
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Figure 3. Better patient-physician partnership is associated 
with lower number of exacerbations in past 12 months (as 
recorded by the physician; P<0.001). Shading represents 
one standard error.
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Figure 4. Better patient-physician partnership is 
associated with improved EQ-5D utility score (P<0.001). 
QoL=quality of life. Shading represents one standard error.
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Figure 5. Better patient-physician partnership is associated 
with fewer sleep disturbances in the past 4 weeks 
(P<0.001). Shading represents one standard error.
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associated with partnership (P<0.05) to the 
extent that patients who are more satisfied 
with their inhaler are more likely to have good 
partnership with their physician than those who 
are dissatisfied with their device.
DISCUSSION
The importance of partnership between 
the asthmatic patient and their physician is 
widely recognized by the medical community. 
The aim of the present study was to provide 
evidence from real-world observational data to 
objectively assess the impact on clinical and 
patient-reported outcomes for asthma patients 
with good “partnership.”
The DSP collects data from patients and 
physicians, and several important clinical 
and disease diagnosis data points can be 
used to investigate the same subject/clinical 
assessment. A good partnership is a strong 
alignment between patient and physician on 
these variables, for which it is argued that a high 
degree of alignment can only be achieved if good 
communication exists between the patient and 
the physician.
A number of clinical criteria were selected 
that accurately record the status of disease, the 
confirmed clinical assessment, improvement or 
decline in disease, and well-being of the patient. 
These were measured for each pairing of patient 
and physician and compared with the quality of 
partnership in each pairing.
It might be expected that parameters such as 
the patient’s age, gender, occupation, smoking 
status, and number of visits to the doctor would 
have an association with the degree of patient-
physician partnership in terms of time and 
quality of patient and physician interactions, 
but this does not appear to be the case. Further 
work is needed to understand the role of these 
patient characteristics.
Figure 6. Better patient-physician partnership is associated 
with fewer symptom increases not severe enough to consult 
physician (as reported by patient; P<0.001). Shading 
represents one standard error.
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Figure 7. Better patient-physician partnership is associated 
with less restriction on lifestyle (P<0.01). Shading 
represents one standard error.































Figure 8. Better patient-physician partnership is associated 
with fewer days lost at work/school in past 12 months due 
to asthma (P<0.05). Shading represents one standard error.
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Despite the limitations of the DSP approach 
acknowledged in the methodology, the study 
has demonstrated an association between good 
partnership and asthma disease outcome for 
the patient. Undoubtedly, as reported in the 
literature, physician-patient communication 
is an aspect that influences the depth of 
partnership and similarly the widely reported 
need to improve the level of patient disease 
awareness and education will be influential in 
the quality of communication between physician 
and patient.
The inhaler device and patient satisfaction 
with the device is one marker of a good 
partnership, which in turn correlates with a more 
positive outcome of the patient. It is suggested 
that assessing patient satisfaction with device 
can be a swift observation for determining 
quality of partnership and providing the basis 
for a relationship between physician and patient 
that fosters an opportunity for improved clinical 
outcomes. It would be valuable to investigate this 
finding further, perhaps through a longitudinal 
study including an assessment of the benefits of 
physician education to improve patient-physician 
partnership and associated patient outcomes.
In conclusion, partnership is dependent 
on good communication between the patient 
and the physician.8,9 A key measure of good 
communication is alignment between the 
patient and physician on the impact of 
asthma. This study demonstrates that good 
alignment on these factors is associated with 
better outcome for the patient. It was observed 
that satisfaction with choice of device is an 
important marker for partnership between the 
physician and the patient. One possible way 
to encourage partnership would be to invest in 
patient education to improve patients’ ability 
to contribute. Further work is required to 
understand and to promote improvement in 
alignment between the physician and patient.
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